Sangamo Therapeutics (SGMO) Tops Q3 EPS by 10c, Revenues Beat

Go back to Sangamo Therapeutics (SGMO) Tops Q3 EPS by 10c, Revenues Beat
Sangamo Biosciences, Inc. (NASDAQ: SGMO) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $9.91 
Open $0.18    52 Week Low $3.10 
Day High $0.18    P/E N/A 
Day Low $0.18    EPS $-0.48 
Volume 10